| 0 |
INFLAMMATION OF LACRIMAL PASSAGE |
1 |
0.0200 |
| 1 |
PELVIC OPERATION |
1 |
0.0152 |
| 2 |
WRONG PRODUCT PROCURED |
1 |
0.0152 |
| 3 |
ASTHENOPIA |
80 |
0.0145 |
| 4 |
FOREIGN BODY SENSATION IN EYES |
80 |
0.0125 |
| 5 |
CORNEAL CYST |
1 |
0.0103 |
| 6 |
ACUTE RIGHT VENTRICULAR FAILURE |
1 |
0.0059 |
| 7 |
KERATOCONUS |
2 |
0.0053 |
| 8 |
EYE DISCHARGE |
54 |
0.0052 |
| 9 |
PRODUCT INTOLERANCE |
1 |
0.0045 |
| 10 |
RHEUMATOID VASCULITIS |
1 |
0.0044 |
| 11 |
INJURY CORNEAL |
2 |
0.0038 |
| 12 |
INSTILLATION SITE DISCHARGE |
1 |
0.0038 |
| 13 |
REACTION TO PRESERVATIVES |
3 |
0.0037 |
| 14 |
SUPERFICIAL INJURY OF EYE |
4 |
0.0037 |
| 15 |
CHEMICAL BURNS OF EYE |
1 |
0.0036 |
| 16 |
OPEN ANGLE GLAUCOMA |
2 |
0.0033 |
| 17 |
EYE IRRITATION |
175 |
0.0030 |
| 18 |
GLASSY EYES |
2 |
0.0028 |
| 19 |
OCULAR HYPERAEMIA |
129 |
0.0027 |
| 20 |
INSTILLATION SITE PRURITUS |
1 |
0.0027 |
| 21 |
PRODUCT DROPPER ISSUE |
2 |
0.0025 |
| 22 |
EYE PRURITUS |
83 |
0.0025 |
| 23 |
LAGOPHTHALMOS |
1 |
0.0024 |
| 24 |
DRY EYE |
122 |
0.0024 |
| 25 |
CENTRAL VENOUS CATHETER REMOVAL |
1 |
0.0021 |
| 26 |
EYELID IRRITATION |
5 |
0.0020 |
| 27 |
BLEPHARAL PIGMENTATION |
1 |
0.0020 |
| 28 |
EYE ALLERGY |
3 |
0.0019 |
| 29 |
LACRIMATION INCREASED |
58 |
0.0019 |
| 30 |
INSTILLATION SITE ERYTHEMA |
1 |
0.0019 |
| 31 |
ABNORMAL SENSATION IN EYE |
8 |
0.0019 |
| 32 |
EYE PAIN |
104 |
0.0018 |
| 33 |
EUSTACHIAN TUBE DYSFUNCTION |
1 |
0.0017 |
| 34 |
CHEMICAL BURN |
2 |
0.0017 |
| 35 |
LUMBAR RADICULOPATHY |
2 |
0.0017 |
| 36 |
MEDICATION RESIDUE PRESENT |
8 |
0.0017 |
| 37 |
CHALAZION |
1 |
0.0016 |
| 38 |
MACULAR FIBROSIS |
1 |
0.0015 |
| 39 |
SCLERAL HYPERAEMIA |
1 |
0.0015 |
| 40 |
CYTOKINE STORM |
1 |
0.0015 |
| 41 |
CORNEAL ABRASION |
2 |
0.0015 |
| 42 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
8 |
0.0014 |
| 43 |
EYELID MARGIN CRUSTING |
4 |
0.0014 |
| 44 |
EXCESSIVE EYE BLINKING |
2 |
0.0014 |
| 45 |
OCULAR DISCOMFORT |
15 |
0.0013 |
| 46 |
CORNEAL TRANSPLANT |
1 |
0.0013 |
| 47 |
RETINAL TEAR |
3 |
0.0012 |
| 48 |
ENDOCRINE OPHTHALMOPATHY |
1 |
0.0012 |
| 49 |
EYELIDS PRURITUS |
3 |
0.0010 |
| 50 |
INNER EAR DISORDER |
1 |
0.0009 |
| 51 |
INSTILLATION SITE REACTION |
1 |
0.0009 |
| 52 |
VISION BLURRED |
126 |
0.0009 |
| 53 |
CORNEAL DISORDER |
2 |
0.0009 |
| 54 |
INSTILLATION SITE IRRITATION |
1 |
0.0008 |
| 55 |
INSTILLATION SITE PAIN |
2 |
0.0008 |
| 56 |
OBLITERATIVE BRONCHIOLITIS |
1 |
0.0008 |
| 57 |
THERAPEUTIC PROCEDURE |
1 |
0.0007 |
| 58 |
CONNECTIVE TISSUE DISORDER |
1 |
0.0007 |
| 59 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
1 |
0.0007 |
| 60 |
DARK CIRCLES UNDER EYES |
1 |
0.0007 |
| 61 |
NIGHT BLINDNESS |
1 |
0.0006 |
| 62 |
SEBORRHOEIC DERMATITIS |
1 |
0.0006 |
| 63 |
EYELID OEDEMA |
7 |
0.0006 |
| 64 |
PRODUCT COUNTERFEIT |
1 |
0.0006 |
| 65 |
ERYTHEMA OF EYELID |
3 |
0.0006 |
| 66 |
METAMORPHOPSIA |
1 |
0.0005 |
| 67 |
DENTAL CARE |
1 |
0.0005 |
| 68 |
PATIENT DISSATISFACTION WITH TREATMENT |
1 |
0.0005 |
| 69 |
MULTI-ORGAN DISORDER |
1 |
0.0005 |
| 70 |
SWELLING OF EYELID |
3 |
0.0005 |
| 71 |
EYE SWELLING |
17 |
0.0005 |
| 72 |
EYELID DISORDER |
1 |
0.0004 |
| 73 |
BLINDNESS TRANSIENT |
3 |
0.0004 |
| 74 |
CHEMICAL BURN OF SKIN |
1 |
0.0004 |
| 75 |
ENDODONTIC PROCEDURE |
1 |
0.0004 |
| 76 |
SUBDURAL HAEMORRHAGE |
1 |
0.0004 |
| 77 |
ULCERATIVE KERATITIS |
1 |
0.0004 |
| 78 |
PERIORBITAL SWELLING |
2 |
0.0004 |
| 79 |
PRODUCT CONTAINER ISSUE |
3 |
0.0003 |
| 80 |
ADENOVIRUS INFECTION |
1 |
0.0003 |
| 81 |
PRODUCT PACKAGING ISSUE |
3 |
0.0003 |
| 82 |
EYE INFLAMMATION |
3 |
0.0003 |
| 83 |
SKIN EROSION |
1 |
0.0003 |
| 84 |
FACIAL PARESIS |
1 |
0.0003 |
| 85 |
PRODUCT CONTAMINATION |
1 |
0.0003 |
| 86 |
SCLERODERMA |
1 |
0.0003 |
| 87 |
LIQUID PRODUCT PHYSICAL ISSUE |
2 |
0.0003 |
| 88 |
EPIGASTRIC DISCOMFORT |
1 |
0.0003 |
| 89 |
BLEPHARITIS |
1 |
0.0002 |
| 90 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 91 |
PRODUCT DISPENSING ISSUE |
1 |
0.0002 |
| 92 |
HORDEOLUM |
1 |
0.0002 |
| 93 |
RHINITIS ALLERGIC |
1 |
0.0002 |
| 94 |
INTERVERTEBRAL DISC DEGENERATION |
2 |
0.0002 |
| 95 |
PRODUCT QUALITY ISSUE |
28 |
0.0002 |
| 96 |
EXPIRED DRUG ADMINISTERED |
1 |
0.0002 |
| 97 |
PRODUCT COLOUR ISSUE |
1 |
0.0002 |
| 98 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 99 |
DECREASED ACTIVITY |
2 |
0.0002 |
| 100 |
EYE DISORDER |
6 |
0.0002 |
| 101 |
GASTRIC ULCER HAEMORRHAGE |
1 |
0.0002 |
| 102 |
MACULAR OEDEMA |
1 |
0.0002 |
| 103 |
MADAROSIS |
2 |
0.0002 |
| 104 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 105 |
CATARACT OPERATION |
1 |
0.0002 |
| 106 |
MACULAR DEGENERATION |
2 |
0.0002 |
| 107 |
FIBROMYALGIA |
4 |
0.0002 |
| 108 |
SCOLIOSIS |
1 |
0.0002 |
| 109 |
PHOTOPHOBIA |
3 |
0.0002 |
| 110 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 111 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 112 |
BRONCHIECTASIS |
1 |
0.0001 |
| 113 |
POSTOPERATIVE WOUND INFECTION |
1 |
0.0001 |
| 114 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 115 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 116 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 117 |
ONYCHOCLASIS |
1 |
0.0001 |
| 118 |
HAND FRACTURE |
1 |
0.0001 |
| 119 |
PULMONARY ARTERIAL HYPERTENSION |
2 |
0.0001 |
| 120 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 121 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 122 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 123 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 124 |
NAIL DISORDER |
1 |
0.0001 |
| 125 |
FACIAL PAIN |
1 |
0.0001 |
| 126 |
GLAUCOMA |
2 |
0.0001 |
| 127 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 128 |
CATARACT |
6 |
0.0001 |
| 129 |
INABILITY TO AFFORD MEDICATION |
1 |
0.0001 |
| 130 |
DRY THROAT |
1 |
0.0001 |
| 131 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 132 |
SKIN LACERATION |
1 |
0.0001 |
| 133 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
1 |
0.0001 |
| 134 |
FOOT DEFORMITY |
1 |
0.0001 |
| 135 |
VISUAL IMPAIRMENT |
11 |
0.0001 |
| 136 |
EYE INFECTION |
1 |
0.0001 |
| 137 |
CYTOPENIA |
1 |
0.0001 |
| 138 |
INTRAOCULAR PRESSURE INCREASED |
1 |
0.0001 |
| 139 |
MYDRIASIS |
1 |
0.0001 |
| 140 |
ROTATOR CUFF SYNDROME |
1 |
0.0001 |
| 141 |
GASTRITIS |
2 |
0.0001 |
| 142 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 143 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 144 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 145 |
THYROID DISORDER |
1 |
0.0001 |
| 146 |
LUNG INFECTION |
1 |
0.0001 |
| 147 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 148 |
DRUG INEFFECTIVE |
83 |
0.0001 |
| 149 |
HIP FRACTURE |
2 |
0.0001 |
| 150 |
BACK DISORDER |
1 |
0.0001 |
| 151 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 152 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 153 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 154 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 155 |
RASH PRURITIC |
3 |
0.0001 |
| 156 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 157 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 158 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 159 |
FRACTURE |
1 |
0.0001 |
| 160 |
GASTRIC ULCER |
1 |
0.0001 |
| 161 |
HERNIA |
1 |
0.0001 |
| 162 |
HAEMORRHOIDS |
1 |
0.0001 |
| 163 |
NASAL CONGESTION |
3 |
0.0001 |
| 164 |
DISABILITY |
1 |
0.0001 |
| 165 |
SINUS DISORDER |
1 |
0.0001 |
| 166 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 167 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 168 |
MOUTH ULCERATION |
1 |
0.0000 |
| 169 |
OSTEOARTHRITIS |
2 |
0.0000 |
| 170 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 171 |
BALANCE DISORDER |
4 |
0.0000 |
| 172 |
PRODUCT DOSE OMISSION |
3 |
0.0000 |
| 173 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 174 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 175 |
ORAL PAIN |
1 |
0.0000 |
| 176 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 177 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 178 |
SKIN IRRITATION |
2 |
0.0000 |
| 179 |
NEURALGIA |
1 |
0.0000 |
| 180 |
OSTEONECROSIS OF JAW |
1 |
0.0000 |
| 181 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 182 |
JOINT STIFFNESS |
1 |
0.0000 |
| 183 |
HAEMOPTYSIS |
1 |
0.0000 |
| 184 |
NECK PAIN |
2 |
0.0000 |
| 185 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 186 |
HYPERSOMNIA |
1 |
0.0000 |
| 187 |
HERPES ZOSTER |
2 |
0.0000 |
| 188 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 189 |
APHASIA |
1 |
0.0000 |
| 190 |
HYPERSENSITIVITY |
6 |
0.0000 |
| 191 |
CYSTITIS |
1 |
0.0000 |
| 192 |
RHINORRHOEA |
2 |
0.0000 |
| 193 |
SWELLING FACE |
2 |
0.0000 |
| 194 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 195 |
VIRAL INFECTION |
1 |
0.0000 |
| 196 |
NIGHTMARE |
1 |
0.0000 |
| 197 |
RASH MACULAR |
1 |
0.0000 |
| 198 |
COVID-19 |
5 |
0.0000 |
| 199 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
0.0000 |
| 200 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 201 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 202 |
EPISTAXIS |
2 |
0.0000 |
| 203 |
PERIPHERAL SWELLING |
4 |
0.0000 |
| 204 |
ARTHRITIS |
2 |
0.0000 |
| 205 |
DRY MOUTH |
2 |
0.0000 |
| 206 |
BLINDNESS |
1 |
0.0000 |
| 207 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 208 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 209 |
HYPERHIDROSIS |
3 |
0.0000 |
| 210 |
HYPOACUSIS |
1 |
0.0000 |
| 211 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 212 |
DRY SKIN |
3 |
0.0000 |
| 213 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 214 |
TINNITUS |
1 |
0.0000 |
| 215 |
ABDOMINAL PAIN |
5 |
0.0000 |
| 216 |
MIGRAINE |
2 |
0.0000 |
| 217 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 218 |
SINUSITIS |
2 |
0.0000 |
| 219 |
THERAPY CESSATION |
1 |
0.0000 |
| 220 |
ILLNESS |
2 |
0.0000 |
| 221 |
INFLAMMATION |
1 |
0.0000 |
| 222 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 223 |
DERMATITIS ATOPIC |
1 |
0.0000 |
| 224 |
PANCREATITIS |
1 |
0.0000 |
| 225 |
CONSTIPATION |
4 |
0.0000 |
| 226 |
FALL |
6 |
0.0000 |
| 227 |
DYSPHONIA |
1 |
0.0000 |
| 228 |
SURGERY |
1 |
0.0000 |
| 229 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 230 |
DISCOMFORT |
1 |
0.0000 |
| 231 |
FEELING HOT |
1 |
0.0000 |
| 232 |
PNEUMONIA |
5 |
0.0000 |
| 233 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 234 |
DEHYDRATION |
2 |
0.0000 |
| 235 |
ERYTHEMA |
3 |
0.0000 |
| 236 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 237 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 238 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 239 |
DYSGEUSIA |
1 |
0.0000 |
| 240 |
CONDITION AGGRAVATED |
4 |
0.0000 |
| 241 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 242 |
PRURITUS |
5 |
0.0000 |
| 243 |
BACK PAIN |
3 |
0.0000 |
| 244 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 245 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 246 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 247 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 248 |
HEADACHE |
7 |
0.0000 |
| 249 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 250 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 251 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 252 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 253 |
BREAST CANCER |
1 |
0.0000 |
| 254 |
CARDIAC DISORDER |
1 |
0.0000 |
| 255 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 256 |
CONTUSION |
1 |
0.0000 |
| 257 |
HEART RATE INCREASED |
1 |
0.0000 |
| 258 |
SYNCOPE |
1 |
0.0000 |
| 259 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 260 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 261 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 262 |
ARTHRALGIA |
4 |
0.0000 |
| 263 |
INFLUENZA |
1 |
0.0000 |
| 264 |
JOINT SWELLING |
1 |
0.0000 |
| 265 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 266 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 267 |
PAIN |
5 |
0.0000 |
| 268 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 269 |
DIZZINESS |
4 |
0.0000 |
| 270 |
OFF LABEL USE |
7 |
0.0000 |
| 271 |
INSOMNIA |
2 |
0.0000 |
| 272 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 273 |
INFECTION |
1 |
0.0000 |
| 274 |
MALAISE |
3 |
0.0000 |
| 275 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 276 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 277 |
PARAESTHESIA |
1 |
0.0000 |
| 278 |
DIARRHOEA |
4 |
0.0000 |
| 279 |
TREMOR |
1 |
0.0000 |
| 280 |
URTICARIA |
1 |
0.0000 |
| 281 |
MYALGIA |
1 |
0.0000 |
| 282 |
PYREXIA |
2 |
0.0000 |
| 283 |
MUSCLE SPASMS |
1 |
0.0000 |
| 284 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 285 |
RASH |
2 |
0.0000 |
| 286 |
FEELING ABNORMAL |
1 |
0.0000 |
| 287 |
NAUSEA |
3 |
0.0000 |
| 288 |
COUGH |
1 |
0.0000 |
| 289 |
DYSPNOEA |
2 |
0.0000 |
| 290 |
ANXIETY |
1 |
0.0000 |
| 291 |
ASTHENIA |
1 |
0.0000 |
| 292 |
FATIGUE |
2 |
0.0000 |
| 293 |
DEATH |
2 |
0.0000 |
| 294 |
VOMITING |
1 |
0.0000 |